"10.1371_journal.pone.0020934","plos one","2011-06-21T00:00:00Z","Nai-Kuei Huang; Jung-Hsin Lin; Jiun-Tsai Lin; Chia-I Lin; Eric Minwei Liu; Chun-Jung Lin; Wan-Ping Chen; Yuh-Chiang Shen; Hui-Mei Chen; Jhih-Bin Chen; Hsing-Lin Lai; Chieh-Wen Yang; Ming-Chang Chiang; Yu-Shuo Wu; Chen Chang; Jiang-Fan Chen; Jim-Min Fang; Yun-Lian Lin; Yijuang Chern","National Research Institute of Chinese Medicine, Taipei, Taiwan; Division of Mechanics, Research Center for Applied Sciences, Academia Sinica, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; School of Pharmacy, National Taiwan University, Taipei, Taiwan; Department of Chemistry, National Taiwan University, Taipei, Taiwan; The Genomics Research Center, Academia Sinica, Taipei, Taiwan; Graduate Institute of Biotechnology, Chinese Culture University, Taipei, Taiwan; Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, United States of America","Conceived and designed the experiments: N-KH J-HL J-MF Y-LL YC. Performed the experiments: J-TL C-IL EML C-JL W-PC Y-CS H-MC J-BC H-LL C-WY M-CC Y-SW CC. Analyzed the data: N-KH J-HL CC J-MF Y-LL YC. Contributed reagents/materials/analysis tools: J-FC. Wrote the paper: J-HL J-MF YC.","The authors have read the journals policy and have the following conflicts: based on results of the present study, two pending patent applications regarding the possible therapeutic use of T1-11 in patients with HD were submitted to patent offices in the US, China, and Taiwan. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","06","Nai-Kuei Huang","NKH",19,TRUE,5,13,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
